alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

CERTIFICATIONS

Exhibit 31

SECTION 302 CERTIFICATION

I, Clive de Larrabeiti, certify that:

1. I have reviewed this interim quarterly report on Form 10-QSB of Mayfair
Mining & Minerals, Inc., for the period ended June 30, 2006;

2. Based on my knowledge, this interim quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
quarterly report;

3. Based on my knowledge, the financial statements, and other financial
information included in this interim quarterly report, fairly present in all
material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this interim
quarterly report;

4. As the sole certifying officer, I am responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-14 and 15d-14) for the registrant and I have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to me by others within those entities, particularly during the
period in which this annual report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this interim
quarterly report (the "Evaluation Date"); and

c) presented in this interim quarterly report my conclusions about the
effectiveness of the disclosure controls and procedures based on my evaluation
as of the Evaluation Date;

5. I have disclosed, based on my most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of my most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

By /s/ Clive de Larrabeiti
   -----------------------
Date: September 19, 2006

Clive de Larrabeiti
President, Chief Executive Officer and Director
**Exhibit 32.1**

 

WrittenStatement of Chief Executive Officer Pursuant to Section 906 of theSarbanes-Oxley Act of 2002

 

The undersigned, the ChiefExecutive Officer of American Bank Holdings, Inc. (The “Company”), herebycertifies that to his knowledge on the date hereof:

 

(a)          TheQuarterly Report on Form 10-Q of the Company for the Quarter EndedSeptember 30, 2003 filed on the date hereof with the Securities andExchange Commission (the “Report”) fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(b)         Informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

 

| /s/ Phillip  C. Bowman                 |   |
|----------------------------------------|--------|
| Phillip C.  Bowman                     |
| President  and Chief Executive Officer |
| November 14,  2003                |

 

A signed original of thiswritten statement required by Section 906 has been provided to AmericanBank Holdings, Inc. and will be retained by American Bank Holdings, Inc. Andfurnished to the Securities and Exchange Commission or its staff upon request.

 

----
### §10553. Annual report to Congress; grant accountability

#### (a) Annual report

Not later than November 30th of each year, the COPS Director and the BJA Director shall each submit a report to the Congress regarding the activities carried out under this subchapter. Each such report shall include, for the preceding fiscal year, the number of grants funded under this subchapter, the amount of funds provided under those grants, and the activities for which those funds were used.

#### (b) Grant accountability

Section 10706 of this title (relating to grant accountability) shall apply to grants awarded by the COPS Director and the BJA Director under this subchapter. For purposes of the preceding sentence, any references in section 10706 of this title to the Attorney General shall be considered references to the COPS Director or the BJA Director, as appropriate, and any references in that section to subchapter XXXVIII shall be considered references to this subchapter.

(Pub. L. 90–351, title I, §2703, as added Pub. L. 106–386, div. B, title I, §1108(b), Oct. 28, 2000, 114 Stat. 1502; amended Pub. L. 109–271, §8(j)(2), Aug. 12, 2006, 120 Stat. 767; Pub. L. 115–141, div. S, title V, §502(3), Mar. 23, 2018, 132 Stat. 1130.)

#### **Editorial Notes**

#### Codification

Section was formerly classified to section 3797c of Title 42, The Public Health and Welfare, prior to editorial reclassification and renumbering as this section.

#### Amendments

2018—Pub. L. 115–141, §502(3)(A), inserted "; grant accountability" after "Congress" in section catchline.

Pub. L. 115–141, §502(3)(B)–(D), designated existing provisions as subsec. (a), inserted heading, substituted "COPS Director and the BJA Director shall each" for "Director shall", and added subsec. (b).

2006—Pub. L. 109–271 substituted "Director" for "Attorney General".
§ 6001.102 Agency designees. For purposes of 5 CFR part 2635, the following Department of Transportation officials are agency designees within the meaning of 5 CFR 2635.102(b): ( a ) The Designated Agency Ethics Official;
( b ) The Alternate Agency Ethics Official;
( c ) The Deputy Ethics Officials; and
( d ) As designated by Deputy Ethics Officials, legal counsel in regional and other offices.
**EXHIBIT 32.1**

 

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned herebycertifies in his capacity as Chief Executive Officer of Belmar Capital Fund LLC(the Fund), that based on his knowledge:

 

(a)                     the AnnualReport of the Fund on Form 10-K for the year ended December 31, 2007(the Report) fully complies with the requirements of Section 13(a) ofthe Securities Exchange Act of 1934, as amended; and

 

(b)                    theinformation contained in the Report fairly presents, in all material respects,the financial condition and the results of operations of the Fund for suchperiod.

 

 

Date: February 29,2008

 

 
|   | /s/ Thomas E. Faust Jr.                      |
|--------|----------------------------------------------|
|   | Thomas E. Faust Jr.  Chief Executive Officer |

 

 

A signed original of thiswritten statement required by Section 906 has been provided to the Fundand will be retained by the Fund and furnished to the Securities and ExchangeCommission or its staff upon request.

 

----
§ 536.307 Treatment of a retained rate as basic pay for other purposes. ( a ) A retained rate is considered to be an employee's rate of basic pay for the purpose of computing or applying— ( 1 ) Retirement deductions, contributions, and benefits under 5 U.S.C. chapters 83 and 84;
( 2 ) Life insurance premiums and benefits under 5 U.S.C. chapter 87;
( 3 ) Premium pay under 5 U.S.C. chapter 55, subchapter V, and 5 CFR part 532 and part 550, subparts A and I;
( 4 ) Severance pay under 5 U.S.C. 5595 and 5 CFR part 550, subpart G;
( 5 ) Post differentials under 5 U.S.C. 5925 and danger pay allowances under 5 U.S.C. 5928;
( 6 ) Nonforeign area cost-of-living allowances and post differentials under 5 U.S.C. 5941(a) and 5 CFR part 591, subpart B;
( 7 ) Lump-sum payments for accumulated and annual leave under 5 CFR part 550, subpart L;
( 8 ) General Schedule pay administration provisions (e.g., promotion increases) to the extent provided in 5 CFR part 531, subpart B;
( 9 ) Pay administration provisions for prevailing rate employees to the extent provided in 5 CFR part 532;
( 10 ) Adverse action provisions in 5 CFR part 752;
( 11 ) Other provisions as specified in other statutes or regulations; and
( 12 ) Payments and benefits equivalent to those listed in this section under other legal authorities, as determined by the head of the agency or other authorized official responsible for administering such payments or benefits.
( b ) For the purpose of applying other laws and regulations not listed in paragraph (a) of this section to an employee receiving a retained rate, the employee's rate of basic pay is deemed to be the applicable maximum rate of basic pay for the employee's position of record (e.g., the maximum rate of basic pay for a locality rate range or special rate range, as applicable, for the purpose of computing a percentage-based award under 5 CFR 451.104(g)).
[70 FR 31310, May 31, 2005, as amended at 73 FR 66156, Nov. 7, 2008]
# L_2018215EN.01003201.xml

| 23.8.2018 | EN | Official Journal of the European Union | L 215/32 |
| --- | --- | --- | --- |

23.8.2018

EN

Official Journal of the European Union

L 215/32

---

DECISION OF THE EEA JOINT COMMITTEE

No 235/2016

of 2 December 2016

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1173]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Regulation (EU) 2016/1688 of 20 September 2016 amending Annex VII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards skin sensitisation (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Regulation (EU) 2016/1688 of 20 September 2016 amending Annex VII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards skin sensitisation (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 12zc (Regulation (EC) No 1907/2006 of the European Parliament of the Council) of Chapter XV of Annex II to the EEA Agreement:

| ‘— | 32016 R 1688: Commission Regulation (EU) 2016/1688 of 20 September 2016 (OJ L 255, 21.9.2016, p. 14).’ |
| --- | --- |

‘—

32016 R 1688: Commission Regulation (EU) 2016/1688 of 20 September 2016 (OJ L 255, 21.9.2016, p. 14).’

Article 2

The text of Regulation (EU) 2016/1688 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 3 December 2016, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 2 December 2016.

For the EEA Joint Committee

The President

Bergdís ELLERTSDÓTTIR

---

(1)  
  OJ L 255, 21.9.2016, p. 14.

1

(*1)  No constitutional requirements indicated.

*1

---
JP Morgan Chase 

Fourth Court of Appeals

San Antonio, Texas

January 9, 2015

No. 04-14-00864-CV

Jeremil RODRIGUEZ,

Appellant

v.

JP MORGAN CHASE BANK,

Appellee

From the 25th Judicial District Court, Guadalupe County, Texas

Trial Court No. 14-0255-CV

Honorable W.C. Kirkendall, Judge Presiding

ORDER

The clerk’s record was originally due on January 5, 2015. On January 7, 2015, the trial 

court clerk filed a Notification of Late Record, stating that the clerk’s record is complete, but has 

not been filed because appellant has failed to pay or make arrangements to pay the clerk’s fee for 

preparing the record.

It is therefore ORDERED that appellant provide written proof to this court no later than

January 19, 2015 that either (1) the clerk’s fee has been paid or arrangements have been made to 

pay the clerk’s fee; or (2) appellant is entitled to appeal without paying the clerk’s fee. If 

appellant fails to file such written proof within the time provided, this appeal will be dismissed 

for want of prosecution. See TEX. R. APP. P. 37.3(b). 

_________________________________

Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 9th day of January, 2015.

___________________________________

Keith E. Hottle

Clerk of Court
Exhibit 4(h)  



	PROTECTIVE LIFE INSURANCE COMPANY	 	P. O. BOX 10648	 	BIRMINGHAM, ALABAMA	 	35202-0648
	





MIMIMUM ANNUITIZATION VALUE ENDORSEMENT  


We
are amending the Contract to which this endorsement is attached by adding the following provisions: 



Minimum Annuitization Value—If the Annuity Commencement Date is on the {Nth} Contract Anniversary, or within {W} days thereafter, and if you
select an Annuity Option providing either: i) life income, with or without a certain period; or,  ii) a certain period of at least {X} years, the
amount we apply to the Annuity Option will not be less than the greater of: 



	•
	the
Contract Value; or



	•
	aggregate
Purchase Payments less an adjustment for each surrender. 







For
the purpose of calculating the minimum annuitization value, the adjustment for each partial surrender will equal the amount that reduces the minimum annuitization value in the same proportion that
the amount surrendered reduced the Contract Value as of the Valuation Period during which that surrender was taken. 


Provided
the conditions set out in the Contract for changing the Annuity Commencement Date are met, we will accept your Written Notice changing the Annuity Commencement Date to a date that qualifies
for the minimum annuitization value. We will calculate the minimum annuitization value as of the Valuation Period that contains the Annuity Commencement Date. 


Termination—This endorsement will automatically terminate upon the earliest of: 


	(a)
	the
end of the Valuation Period that contains the {W+1} day after the {Nth} Contract Anniversary; or,



	(b)
	a
cancellation, or full surrender of the Contract. 




Signed
for the company and made a part of the contract as of the Effective date. 


PROTECTIVE
LIFE INSURANCE COMPANY 



	


 



Secretary

	
 	

 




1
Draft - Summary Wood/Pellet Stoves 8/11/2010

0

10

20

30

40

50

60

1 to 2 3 to 5 6 to 10 11 to 20 21 to 40 41+

Number of Manufacturers

Number of Models

No. of Models per Manufacturer

0

5

10

15

20

25

30

1 to 2 3 to 5 6 to 10 11 to 20 21 to 40 41+

Number of Manufacturers

Number of Models

No. of Catalytic Wood Stove Models per 

Manufacturer

0

5

10

15

20

25

1 to 2 3 to 5 6 to 10 11 to 20 21 to 40

Number of Manufacturers

Number of Models

No. of Pellet Stove Models per Manufacturer

0

10

20

30

40

1 to 2 3 to 5 6 to 10 11 to 20 21 to 40 41+

Number of Manufacturers

Number of Models

No. of Non-Catalytic Wood Stove Models per 

Manufacturer
[Federal Register Volume 69, Number 215 (Monday, November 8, 2004)]
[Notices]
[Page 64780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24797]



[[Page 64780]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel, Review of 
Career Transition Award (K22), Mentored Patient-Oriented Research 
Career Development Award (K23), Midcareer Investigator Award in 
Patient-Oriented Research (K24), and Mentored Quantitative Research 
Career Development Award (K25).
    Date: November 9, 2004.
    Time: 8 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Guo HE Zhang, PhD, MD, Scientific Review 
Administrator, National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, National Institutes of Health, 6701 Democracy 
Boulevard, Suite 800, Bethesda, MD 20817, (301) 451-6524, 
<a href="/cdn-cgi/l/email-protection#98e2f0f9f6ffffedd8f5f9f1f4b6f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="72081a131c151507321f131b1e5c1c1b1a5c151d04">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program No. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS.)

    Dated: October 28, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-24797 Filed 11-5-04; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT
32.1





CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of American Bio Medica Corporation (the
"Company") on Form 10-Q for the period ending June 30, 2009 as filed with the
Securities and Exchange Commission on August 14, 2009 (the "Report"), I, Stan
Cipkowski, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:




(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.




/s/ Stan CipkowskiStan
      CipkowskiChief
      Executive OfficerPrincipal
      Executive OfficerAugust
      14, 2009
§ 550.905 Payment of hazard pay differential. ( a ) When an employee performs duty for which a hazard pay differential is authorized, the agency must pay the hazard pay differential for the hours in a pay status on the day (a calendar day or a 24-hour period, when designated by the agency) on which the duty is performed, except as provided in paragraph (b) of this section. Hours in a pay status for work performed during a continuous period extending over 2 days must be considered to have been performed on the day on which the work began, and the allowable differential must be charged to that day.
( b ) Employees may not be paid a hazardous duty differential for hours for which they receive annual premium pay for regularly scheduled standby duty under § 550.141, annual premium pay for administratively uncontrollable overtime work under § 550.151, or availability pay for criminal investigators under § 550.181.
[64 FR 69180, Dec. 10, 1999]
§ 630.206 Minimum charge. ( a ) Unless an agency establishes a minimum charge of less than one hour, or establishes a different minimum charge through negotiations, the minimum charge for leave is one hour, and additional charges are in multiples thereof. If an employee is unavoidably or necessarily absent for less than one hour, or tardy, the agency, for adequate reason, may excuse him without charge to leave.
( b ) When an employee is charged with leave for an unauthorized absence or tardiness, the agency may not require him to perform work for any part of the leave period charged against his account.
[33 FR 12475, Sept. 4, 1968, as amended at 38 FR 18446, July 11, 1973; 38 FR 26601, Sept. 24, 1973]
Exhibit 32.2



Certification of Chief Financial Officer



Pursuant to 18 U.S.C. ss. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of FIRST ADVANTAGE
CORPORATION (the Company) hereby certifies, to such officers knowledge, that:



(i) the accompanying Quarterly Report on Form 10-Q/A of the Company for the quarterly period ended March 31, 2005 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended; and



(ii) the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.



|                     |  |                        
|-------------------- |  | -----------------------
|Date: March 31, 2006 |  | /s/ JOHN LAMSON        
|                     |  | John Lamson            
|                     |  | Chief Financial Officer



The foregoing certification is being
furnished solely to accompany the Report pursuant to 18 U.S.C. ss. 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company,
whether made before or after the date hereof, regardless of any general incorporation language in such filing.
```

[Federal Register: January 29, 2010 (Volume 75, Number 19)]
[Notices]               
[Page 4901]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29ja10-130]                         

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6362]

 
Renewal of the U.S. Advisory Commission for Public Diplomacy

SUMMARY: The Department of State has renewed the Charter of the U.S. 
Advisory Commission for Public Diplomacy.
    The Advisory Commission was originally established under Section 
604 of the United States Information and Exchange Act of 1948, as 
amended (22 U.S.C. 1469) and Section 8 of Reorganization Plan Numbered 
2 of 1977. It was reauthorized pursuant to Public Law 111-70 (2009).
    The Commission is a bipartisan panel appointed by the President and 
created by Congress in 1948 to assess public diplomacy policies and 
programs of the U.S. government and publicly funded nongovernmental 
organizations. It submits reports to the Congress, the President, and 
the Secretary of State to develop a better understanding of and support 
for public diplomacy programs and activities.

FOR FURTHER INFORMATION CONTACT: Carl Chan, ACPD Executive Director) at 
(202) 632-2823 or via e-mail at chanck@state.gov.

    Dated: January 22, 2010.
Carl Chan,
Executive Director, ACPD, Department of State.
[FR Doc. 2010-1865 Filed 1-28-10; 8:45 am]
BILLING CODE 4710-11-P
```